Condensed Consolidated Statements of Changes in Stockholders’ (Deficit) Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total
Balance at Dec. 31, 2021	$ 2,329	$ 126,581,702	$ (115,899,939)	$ 211,486	$ 10,895,578
Balance (in Shares) at Dec. 31, 2021	23,294,024
Sale of common stock for cash, net of offering costs	$ 106	3,146,834			3,146,940
Sale of common stock for cash, net of offering costs (in Shares)	1,063,514
Stock-based compensation		1,866,989			1,866,989
Common stock issued with convertible debt	$ 3	91,754			91,757
Common stock issued with convertible debt (in Shares)	28,496
Common stock issued for working capital facility	$ 10	302,990			303,000
Common stock issued for working capital facility (in Shares)	100,000
Warrants for services with the issuance of convertible debt		449,474			449,474
Cashless stock option exercise	$ 19	(19)
Cashless stock option exercise (in Shares)	185,111
Cashless warrant exercise
Cashless warrant exercise (in Shares)	1,377
Net loss			(5,300,728)		(5,300,728)
Foreign currency translation				32,740	32,740
Balance at Mar. 31, 2022	$ 2,467	132,439,724	(121,200,667)	244,226	11,485,750
Balance (in Shares) at Mar. 31, 2022	24,672,522
Balance at Dec. 31, 2022	$ 2,532	140,255,234	(140,130,159)	155,929	283,536
Balance (in Shares) at Dec. 31, 2022	25,319,095
Stock-based compensation		840,021			840,021
Shares issued in lieu of interest	$ 55	222,372			222,427
Shares issued in lieu of interest (in Shares)	545,342
Net loss			(5,222,494)		(5,222,494)
Foreign currency translation				(24,066)	(24,066)
Balance at Mar. 31, 2023	$ 2,587	$ 141,317,627	$ (145,352,653)	$ 131,863	$ (3,900,576)
Balance (in Shares) at Mar. 31, 2023	25,864,437